TY - JOUR
T1 - Statistical modeling of immunoprecipitation efficiency of MeRIP-seq data enabled accurate detection and quantification of epitranscriptome
AU - Wang, Haozhe
AU - Chen, Kunqi
AU - Wei, Zhen
AU - Song, Bowen
AU - Zhu, Manli
AU - Su, Jionglong
AU - Nguyen, Anh
AU - Meng, Jia
AU - Wang, Yue
N1 - Publisher Copyright:
© 2025 The Authors
PY - 2025/1
Y1 - 2025/1
N2 - Background: Recent advancements in epitranscriptomics highlight reversible RNA modifications as crucial regulators, with N6-methyladenosine (m6A) being abundant in eukaryotic mRNAs. Immunoprecipitation (IP) with specific antibodies is one of the most prevalent methods for m6A profiling, enabling the isolation of modified RNA for downstream analysis of their functional roles, but no computational methods have been developed to explicitly report a specific variation value in IP efficiencies conveniently, which may hinder the identification of novel modified RNA sites, particularly those with low abundance or less well-characterized. Results: We develop a comprehensive analytical tool, AEEIP,1 for estimating the IP efficiency and correcting antibody bias in epitranscriptomics directly, AEEIP employs a mixture model to estimate the proportion of modification-containing RNA fragments from the source of IP data. Validation with both simulated and real data shows that AEEIP successfully estimates antibody bias across different replicates and experimental conditions, and reveals that this bias may obscure the accurate identification of m6A sites, leading to false negatives in the quantification of m6A-seq data. The proposed method provides reproducible IP efficiency analysis and more robust results for quantifying epitranscriptomics, which is available at: https://github.com/whz991026/AEEIP.
AB - Background: Recent advancements in epitranscriptomics highlight reversible RNA modifications as crucial regulators, with N6-methyladenosine (m6A) being abundant in eukaryotic mRNAs. Immunoprecipitation (IP) with specific antibodies is one of the most prevalent methods for m6A profiling, enabling the isolation of modified RNA for downstream analysis of their functional roles, but no computational methods have been developed to explicitly report a specific variation value in IP efficiencies conveniently, which may hinder the identification of novel modified RNA sites, particularly those with low abundance or less well-characterized. Results: We develop a comprehensive analytical tool, AEEIP,1 for estimating the IP efficiency and correcting antibody bias in epitranscriptomics directly, AEEIP employs a mixture model to estimate the proportion of modification-containing RNA fragments from the source of IP data. Validation with both simulated and real data shows that AEEIP successfully estimates antibody bias across different replicates and experimental conditions, and reveals that this bias may obscure the accurate identification of m6A sites, leading to false negatives in the quantification of m6A-seq data. The proposed method provides reproducible IP efficiency analysis and more robust results for quantifying epitranscriptomics, which is available at: https://github.com/whz991026/AEEIP.
KW - Antibody bias
KW - Epitranscriptome
KW - Immunoprecipitation efficiency
KW - mA
KW - MeRIP-seq
KW - Mixture model
UR - https://www.scopus.com/pages/publications/105014888267
U2 - 10.1016/j.csbj.2025.08.030
DO - 10.1016/j.csbj.2025.08.030
M3 - Article
AN - SCOPUS:105014888267
SN - 2001-0370
VL - 27
SP - 3742
EP - 3752
JO - Computational and Structural Biotechnology Journal
JF - Computational and Structural Biotechnology Journal
ER -